Merrimack Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MACK and other ETFs, options, and stocks.

About MACK

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310.

CEO

Gary L. Crocker

CEOGary L. Crocker

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1993

Founded1993

Employees

—

Employees—

MACK Key Statistics

Market cap

213.84M

Market cap213.84M

Price-Earnings ratio

-177.72

Price-Earnings ratio-177.72

Dividend yield

—

Dividend yield—

Average volume

107.22K

Average volume107.22K

High today

$14.73

High today$14.73

Low today

$14.68

Low today$14.68

Open price

$14.68

Open price$14.68

Volume

45.33K

Volume45.33K

52 Week high

$15.89

52 Week high$15.89

52 Week low

$11.53

52 Week low$11.53

Merrimack Pharmaceuticals

Why Robinhood?

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. Show more

MACK Key Statistics

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310.